Neuronetics, Inc. Common Stock STIM
i
Market dataready · fetched 2026-11-12T00:50:49.028Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:50:15.673103342Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-12T00:50:48.410382+00:00
Neuronetics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | 1.60 | 125.4% | 16.0% | |||
| 45Δ | 1.73 | 141.9% | 15.2% | |||
| 50Δ | 1.87 | 158.5% | 14.4% | |||
| 55Δ | 2.00 | 175.1% | 13.5% | |||
| 60Δ | 2.09 | 166.0% | 11.5% | |||
| 65Δ | 1.67 | 277.7% | 37.9% | 2.18 | 156.9% | 9.5% |
| 70Δ | 1.51 | 290.8% | 32.3% | 2.28 | 147.8% | 7.5% |
| 75Δ | 1.32 | 288.3% | 25.2% | 2.37 | 138.7% | 5.4% |
| 80Δ | 1.13 | 285.1% | 18.1% | 2.46 | 129.6% | 3.4% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.60
- IV
- 125.4%
- B/E move
- 16.0%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.73
- IV
- 141.9%
- B/E move
- 15.2%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.87
- IV
- 158.5%
- B/E move
- 14.4%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.00
- IV
- 175.1%
- B/E move
- 13.5%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.09
- IV
- 166.0%
- B/E move
- 11.5%
65Δ
- Pseudo strike
- 1.67
- IV
- 277.7%
- B/E move
- 37.9%
- Pseudo strike
- 2.18
- IV
- 156.9%
- B/E move
- 9.5%
70Δ
- Pseudo strike
- 1.51
- IV
- 290.8%
- B/E move
- 32.3%
- Pseudo strike
- 2.28
- IV
- 147.8%
- B/E move
- 7.5%
75Δ
- Pseudo strike
- 1.32
- IV
- 288.3%
- B/E move
- 25.2%
- Pseudo strike
- 2.37
- IV
- 138.7%
- B/E move
- 5.4%
80Δ
- Pseudo strike
- 1.13
- IV
- 285.1%
- B/E move
- 18.1%
- Pseudo strike
- 2.46
- IV
- 129.6%
- B/E move
- 3.4%
Options history
Table
| Date | IV (%) |
|---|---|
| 206.75% | |
| 193.86% | |
| 156.34% | |
| 166.86% | |
| 203.22% | |
| 155.51% | |
| 153.68% | |
| 154.86% | |
| 158.30% |
Medical Devices
SYK
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and…
More →TCMD
Tactile Systems Technology, Inc., a medical technology company, is dedicated to the development and supply of medical devices for chronic diseases in the United States. The…
More →TLSI
TriSalus Life Sciences Inc. (TLSI) is an innovative biopharmaceutical firm at the forefront of enhancing cancer therapy through its proprietary localized drug delivery systems,…
More →TMCI
Treace Medical Concepts, Inc., an orthopedic medical device company, is dedicated to the design, manufacture, and marketing of biological devices and / or solutions for foot and…
More →TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the…
More →TNDM
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United States. The company…
More →